The lack of association of marijuana and other recreational drugs with progression to AIDS in the San Francisco Men's Health Study

Annals of Epidemiology

Volumn 6, Issue 4, 1996, Pages 283-289

  Di Franco, Matthew J ^a,e   Sheppard, Haynes W ^b   Hunter, David J ^a,c   Tosteson, Tor D ^d   Ascher, Michael S ^b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b VIRAL AND RICKETTSIAL DISEASE LABORATORY   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d DARTMOUTH MEDICAL SCHOOL   (United States)

^e NONE   (United States)

Author keywords

AIDS; alcohol; laboratory markers; marijuana; Recreational drug use; smoking

Indexed keywords

AMPHETAMINE DERIVATIVE; AMYL NITRITE; CANNABIS; COCAINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIBODY DETECTION; ARTICLE; DISEASE ASSOCIATION; DISEASE COURSE; DRUG ABUSE; HEALTH SURVEY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0030197501     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1047-2797(96)00022-1     Document Type: Article

References (25)

1. 1. Kaslow RA, Blackwelder WC, Ostrow DG, et al. No Evidence for a role of alcohol or other psychoactive drugs in accelerating immunodeficiency in HIV-1-positive individuals. JAMA. 1989;261:3424-29.
2. 2. Ascher MS, Sheppard HW, Winkelstein W Jr, Vittinghoff E. Does drug use cause AIDS? Nature 1993;362:103-104.
3. 3. Stall R, Ostrovv DG. Intravenous drug use, the combination of drugs and sexual activity and HIV infection among gay and bisexual men: The San Francisco Men's Health Study. J Drug Issues. 1989;19:57-73.
4. 4. Stall R, McKusick L, Wiley J, et al. Alcohol and drug use during sexual activity and compliance with safe sex guidelines for AIDS: The AIDS Behavioral Research Project. Health Ed Quart. 1986;13:359-371.
5. 5. Winkelstein W, Lyman DM, Padian N, et al. Sexual practices and risk of infection by the AIDS-associated retrovirus: The San Francisco Men's Health Study. JAMA. 1987;257:321-325.
6. 6. Sheppard HW, Lang W, Ascher MS, et al. The characterization of non-progressors: Long-term HIV-1 infection with stable CD4+ T-cell levels. AIDS. 1993;7:1159-1166.
7. 7. Lang W, Anderson RE, Perkins NS, et al. Clinical, immunologic, and serologic findings in men at risk for acquired immunodeficiency syndrome. JAMA. 1987;257:326-330.
8. 8. Winkelstein W Jr., Samuel M, Padian NS, et al. The San Francisco Men's Health Study. III. Reduction in human immunodeficiency virus transmission among homosexual/bisexual men, 1982-1986. Am J Public Health. 1987;76:685-689.
9. 9. Sheppard HW, Ascher MS, McRae B, et al. The initial immune response to HIV and immune system activation determine the outcome of HIV disease. J Acquit Immune Defic Syndr. 1991;4:704-712.
10. 10. Centers for Disease Control. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR. 1987; 36:3-15.
11. 11. Royce R, Winkelstein W Jr. HIV infection, cigarette smoking and CD4+ T-lymphocyte counts: Preliminary results from the San Francisco Men's Health Study. AIDS. 1990;4:327-333.
12. 12. Doweiko JP. Hematologic aspects of HIV infection. AIDS. 1993; 7:753-757.
13. 13. Lehrman S. U.S. stalls over tests of marijuana to treat AIDS patients. Nature. 1995;374:7-8.
14. 14. Macallan DC, Noble C, Baldwin C, et al. Energy expenditure and wasting in human immunodeficiency virus infection. N Engl J Med. 1995;333:83-88.
15. 15. Anonymous. Donald Abrams' marijuana study. Crit Path AIDS Proj. 1994;30:9-17.
16. 16. Levy JA. The transmission of HIV and factors influencing progression to AIDS. Am J Med. 1993;95:86-100.
17. 17. Levy JA. HIV pathogenesis and long-term survival. AIDS. 1993; 7:1401-1410.
18. H2 switch is a critical step in the etiology of HIV infection. Immunol Today. 1993;14:106-111.
19. 19. Schwartländer B, Bek B, Skarabis H, et al. Improvement of the predictive value of CD4+ lymphocyte count by β2-microglobulin, immunoglobulin A and erythrocyte sedimentation rate. AIDS. 1993; 7:813-821.
20. 20. Fauci AS. Multifactorial nature of human immunodeficiency virus disease: Implications for therapy. Science, 1993;262:1011-1018.
21. 21. Phillips AN, Sabin CA, Bofill M, Janossy G, Lee CA. CD8+ T cell counts up to 10 years from seroconversion. J Acquir Immune Defic Syndr. 1993;6:1176-1177.
22. 22. Margolick JB, Donnenberg AD, Muñoz A, et al. Changes in T and non-T lymphocyte subsets following seroconversion in HIV-1 stable: GD3+ and declining CD3-populations suggest regulatory responses linked to loss of CD4 lymphocytes. J Acquir Immune Defic Syndr. 1993;6:153-161.
23. 23. Buchbinder SP, Katz MH, Mitchell HK, Hessol NA, O'Malley PM, Holmberg SD. Long-term HIV-1 infection without immunologic progression. AIDS. 1994;8:1123-1128.
24. 24. Twigg HL 3rd, Soliman DM, Spain BA. Impaired alveolar macrophage accessory cell function and reduced incidence of lymphocytic alveolitis in HIV-infected patients who smoke. AIDS. 1994;8:611-618.
25. 25. Lifson AR, Buchbinder SP, Sheppard HW, et al. Long-term human immunodeficiency virus infection in asymptomatic homosexual and bisexual men with normal CD4+ lymphocyte counts: Immunologic and virologic characteristics. J Infect Dis. 1991;163:959-965.